PRSS1
Serine protease 1
As of the edition of 20 October 2026, PRSS1 (serine protease 1, UniProt P07477) has 2 drugs tested at it and 3 companies on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P07477
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- Secreted
- Solved structures
- 11
- Disease areas
- Infections; Lungs and airways; Pregnancy and women's health; Urinary and reproductive; Blood and lymph; Digestive system; Heart and blood vessels
- Registered trials of its drugs
- 37
Drugs at this target
| Status | Count |
|---|---|
| Active | 2 |
| Total | 2 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Camostat | Active | Phase 4 | none listed |
| Nafamostat | Active | Phase 4 | none listed |
2 of 2 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Engaged | 3 |
| Total on the list | 3 |